RT Journal Article
T1 Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry.
A1 García-Fernández, Amaya
A1 Esteve-Pastor, María Asunción
A1 Roldán-Rabadán, Inmaculada
A1 Muñiz, Javier
A1 Ruiz Ortiz, Martín
A1 Cequier, Ángel
A1 Bertomeu-Martínez, Vicente
A1 Badimón, Lina
A1 Otero, Déborah
A1 Anguita, Manuel
A1 Lip, Gregory Y H
A1 Marín, Francisco
A1 FANTASIIA investigators, 
K1 Atrial fibrillation
K1 diabetes mellitus
K1 oral anticoagulation
K1 risk factors
AB Atrial fibrillation (AF) patients with diabetes (DM) have high risk of cardiovascular events. To compare clinical characteristics, adverse outcomes and quality of anticoagulation in AF patients regarding DM status. AF patients from FANTASIIA registry were included. Baseline characteristics and comorbidities were recorded. After 2-years follow-up, the association between adverse events and DM was evaluated. 1956 patients (mean age 73.8 ± 9.5 years, 56% male) were analyzed; 574 (29.3%) had DM. Diabetic patients had also high prevalence of hypertension (90.6% vs 76.1%; p  AF Diabetic patients have higher comorbidities and poorer TTR than nondiabetic patients. Low TTR was associated with adverse events. The risk of cardiovascular outcomes was higher in DM patients, with independent association between DM and mortality risk.
YR 2020
FD 2020-06-17
LK http://hdl.handle.net/10668/15684
UL http://hdl.handle.net/10668/15684
LA en
DS RISalud
RD Apr 6, 2025